acure
Desconocido
BATCure: Developing new therapies for Batten disease
AcureOmics AB
participó en un
H2020:
H2020-PHC-2014-2015
The goal of BATCure is to advance the development of new therapeutic options for a group of rare lysosomal diseases - neuronal ceroid lipofu...
2015-12-04 - 2019-06-30 | Financiado
2015-12-04 - 2019-06-30 | Financiado
HUMAN: Health and the Understanding of Metabolism Aging and Nutrition
AcureOmics AB
participó en un
FP7:
Recently intense research identified around 4,000 single nucleotide polymorphisms (SNPs) associated with human age related diseases such as...
Financiado
Financiado
BIOMARGIN: Biomarkers of renal graft injuries in kidney allograft recipients
AcureOmics AB
participó en un
FP7:
In renal allograft recipients, 10-year graft survival has not improved over the past decades. Histological examination of graft biopsies has...
Financiado
Financiado
BOLD: Biology of Liver and Pancreatic Development and Disease
AcureOmics AB
participó en un
FP7:
Aims: provide a cutting edge research training programme encompassing complementary approaches to the investigation of liver and pancreatic...
Financiado
Financiado
* No se disponen de datos de la empresa actual.